SLC7A11 and cancer: Ever since Bannai and Kitamura first identified it in 1980, there has been a significant rise in the number of studies showing the extensive presence of SLC7A11 in different types of cancer, along with its various impacts on cancer development, spread, migration, and poor prognosis (16–26, 43–47).